BioAim Scientific (Kanada)
The Bioaim Human HVEM ELISA kit is a solid phase sandwich ELISA (enzyme-linked immunosorbent assay) for the quantitative measurement of HVEM in Human serum, plasma and cell culture media. An antibody specific for Human HVEM was coated on a 96-well plate. Standards and samples are added to the wells and any HVEM present binds to the immobilized antibody. The wells are washed and biotinylated anti-Human HVEM antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is added to the wells. The wells are again washed and TMB substrate solution is added, which produces a blue color in direct proportion to the amount of HVEM present in the initial sample. The Stop Solution changes the color from blue to yellow, and the microwell absorbances are read at 450 nm.Research Area Apoptosis;
TNF receptor superfamily member 14(HVEM) Background: HVEM (herpesvirus entry mediator), also known as TNFRSF14 and CD270, is a type I membrane protein in the TNF receptor superfamily, and it can both promote and inhibit T cell activity. HVEM is highly expressed on naïve CD4+ T cells, CD8+ T memory cells, regulatory T cells, dendritic cells, monocytes, and neutrophils (4-8). Its expression declines during effector T cell activation but is up-regulated during Treg activation. HVEM functions as a receptor for BTLA, CD160, LIGHT/TNFSF14, and Lymphotoxin-alpha. Ligation of HVEM by LIGHT triggers T cell, monocyte, and neutrophil activation and contributes to Th1 inflammation and cardiac allograft rejection.
ATAR, CD270, HVEA, HVEM, LIGHTR, TR2
Serum, plasma, Cell culture supernatant
|Antigen Name||TNF receptor superfamily member 14|
|Detection Range||32.8-8000 pg/ml|
|Alias||ATAR, CD270, HVEA, HVEM, LIGHTR, TR2|